arrow
W

Wei-Chih Liao

National Taiwan University Hospital
H指数:44
被引数:8,048

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study

达克替尼和阿法替尼一线治疗晚期EGFR突变型非小细胞肺癌患者的有效性和安全性差异: 一项真实世界观察性研究

2024-02-192
OAAI